Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

New Medical Device and Therapeutic Approvals in Otolaryngology: State of the Art Review of 2022.

PMID: 38259521 · 2024

JournalOTO open
Year2024
PMID38259521

Abstract

To review new drugs and devices relevant to otolaryngology approved by the Food and Drug Administration (FDA) in 2022. Publicly available FDA data on drugs and devices approved in 2022. A preliminary screen was conducted to identify drugs and devices relevant to otolaryngology. A secondary screen by members of the American Academy of Otolaryngology-Head and Neck Surgery's (AAO-HNS) Medical Devices and Drugs Committee differentiated between minor updates and new approvals. The final list of drugs

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.